Article
STING activation increases the efficiency of temozolomide in PTEN harbouring glioblastoma cells
12 Jun 2024
Abstract excerpt
Background/aim: Glioblastoma is one of the most aggressive tumours, resistant to all applied therapy regiments and prone to relapse. Median survival rates are therefore only expressed as months. STING agonists are immunomodulatory molecules that activate type I interferon expression, making them potentially useful in regulating the tumour microenvironment. Since PTEN serves as a critical phosphatase in activating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
